相关实验视频
Updated: May 21, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.4K
多模态深度表示学习准确地识别和解释药物向相互作用.
IEEE journal of biomedical and health informatics
|March 20, 2025
概括
联合DTA整合了多模式数据,用于优异的药物向相互作用预测. 这种可解释的深度学习模型改善了结合亲和力预测,并为药物发现提供了洞察力.
科学领域:
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
- 人工智能的人工智能
背景情况:
- 目前的深度学习模型在药物向相互作用预测的多模式生物分子数据上扎.
- 由于数据整合不完整,现有方法的性能和通用性受到限制.
研究的目的:
- 开发一种新的可解释的深度学习框架,UnitedDTA,用于增强药物向亲和力预测.
- 改进多模式生物分子数据 (序列,图形,3D结构) 的整合.
- 提高新药和目标的预测性能和概括性.
主要方法:
- 联合DTA使用对比学习和交叉注意力机制来实现多模式数据集成和对齐.
- 该框架从不同的数据类型中学习统一的歧视性表示.
- 可解释性被纳入,以确定影响结合活动的关键子结构.
主要成果:
- 美国DTA在药物向 afinity 预测的基准数据集上显著优于最先进的方法.
- 该模型显示出卓越的概括能力,特别是对于未见的药物标对.
- 该框架提供了对药物标复杂相互作用的可解释的见解.
结论:
- 联合DTA提供了一种强大而可解释的方法,用于多模式药物向相互作用预测.
- 学习的表示显示了药物发现中更广泛应用的潜力,例如分子性质预测.
- 这一框架提高了计算药物发现中的预测准确性和可解释性.
相关概念视频
Drug-Receptor Interactions
4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K
Drug-Receptor Interaction: Antagonist
2.6K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.6K
Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
3.4K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
3.4K
Quantitative Aspects of Drug-Receptor Interaction
913
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
913

